Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs
- PMID: 11920288
- DOI: 10.1086/339192
Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs
Abstract
From 1982-1998, enhanced sentinel surveillance for acute hepatitis B was conducted in 4 counties in the United States to determine trends in disease incidence and risk factors for infection. During this period, the reported incidence of acute hepatitis B declined by 76.1% from 13.8 cases per 100,000 in 1987 to 3.3 cases per 100,000 in 1998. Cases associated with injection drug use (IDU) decreased by 90.6%, men who have sex with men (MSM) by 63.5%, and heterosexual activity by 50.7%. During 1994-1998, the most commonly reported risk factor for infection was high-risk heterosexual activity (39.8%) followed by MSM activity (14.6%) and IDU (13.8%). Over half of all patients (55.5%) reported treatment for a sexually transmitted disease (STD) or incarceration in a prison or jail prior to their illness, suggesting that more than half of the acute hepatitis B cases might have been prevented through routine hepatitis B immunization in STD clinics and correctional health care programs.
Similar articles
-
Surveillance for acute viral hepatitis - United States, 2007.MMWR Surveill Summ. 2009 May 22;58(3):1-27. MMWR Surveill Summ. 2009. PMID: 19478727
-
Incidence of acute hepatitis B--United States, 1990-2002.MMWR Morb Mortal Wkly Rep. 2004 Jan 2;52(51-52):1252-4. MMWR Morb Mortal Wkly Rep. 2004. PMID: 14704650
-
Surveillance for acute viral hepatitis--United States, 2006.MMWR Surveill Summ. 2008 Mar 21;57(2):1-24. MMWR Surveill Summ. 2008. PMID: 18354374
-
Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.J Med Virol. 2002 Jul;67(3):440-3. doi: 10.1002/jmv.10092. J Med Virol. 2002. PMID: 12116041 Review.
-
Prevention of hepatitis B virus infection.Am Fam Physician. 1993 Mar;47(4):865-74. Am Fam Physician. 1993. PMID: 8438685 Review.
Cited by
-
Prevalence and Trends of Transfusion-Transmissible HBV Infection Among Blood Donors in Southwestern China: A Six-Year Retrospective Study.Int J Gen Med. 2024 Sep 6;17:3907-3918. doi: 10.2147/IJGM.S472609. eCollection 2024. Int J Gen Med. 2024. PMID: 39257611 Free PMC article.
-
The burden of cirrhosis mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities.Lancet Public Health. 2024 Aug;9(8):e551-e563. doi: 10.1016/S2468-2667(24)00131-2. Epub 2024 Jul 14. Lancet Public Health. 2024. PMID: 39004094
-
Is It Time for Treatment as Prevention of Chronic Hepatitis B?Pathogens. 2023 Sep 6;12(9):1137. doi: 10.3390/pathogens12091137. Pathogens. 2023. PMID: 37764945 Free PMC article.
-
Risk Factors for Hepatitis B Virus Transmission in Oman.Oman Med J. 2021 Jul 31;36(4):e287. doi: 10.5001/omj.2021.99. eCollection 2021 Jul. Oman Med J. 2021. PMID: 34405055 Free PMC article.
-
Evaluation of Five International HBV Treatment Guidelines: Recommendation for Resource-Limited Developing Countries Based on the National Study in Nepal.Pathophysiology. 2020 Dec;27(1):3-13. doi: 10.3390/pathophysiology27010002. Epub 2020 Nov 19. Pathophysiology. 2020. PMID: 34321716 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
